Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features

Lecarpentier, 1987, Major alterations in relaxation during cardiac hypertrophy induced by aortic stenosis in guinea pig, Circ Res, 61, 107, 10.1161/01.RES.61.1.107

Doering, 1988, Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy, Cardiovasc Res, 22, 686, 10.1093/cvr/22.10.686

de la Bastie, 1990, Function of the sarcoplasmic reticulum and expression of its Ca2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat, Circ Res, 66, 554, 10.1161/01.RES.66.2.554

Scheuer, 1986, The cardiac hypertrophic response to pathologic and physiologic overload, Circulation, 75, 163

Benjamin, 1989, Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis, Circ Res, 65, 657, 10.1161/01.RES.65.3.657

Boluyt, 1995, Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart, Am J Physiol, 269, H638

Feldman, 1993, Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding, Circ Res, 73, 184, 10.1161/01.RES.73.1.184

Kiss, 1995, Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca2+-ATPase protein levels, Circ Res, 77, 759, 10.1161/01.RES.77.4.759

Cory, 1994, Role of sarcoplasmic reticulum in loss of load-sensitive relaxation in pressure overload cardiac hypertrophy, Am J Physiol, 266, H68

Brilla, 1991, Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy, Circulation, 83, 1771, 10.1161/01.CIR.83.5.1771

Scheuer, 1982, Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats, J Clin Invest, 70, 1300, 10.1172/JCI110729

Bartosova, 1969, The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly, J Physiol, 200, 285, 10.1113/jphysiol.1969.sp008693

Nagai, 1989, Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone, Proc Natl Acad Sci USA, 86, 2966, 10.1073/pnas.86.8.2966

Liang, 1979, Conditioning effects of chronic infusions of dobutamine, J Clin Invest, 64, 613, 10.1172/JCI109501

Morgan, 1991, Cardiac hypertrophy: mechanical, neural and endocrine dependence, Circulation, 83, 13, 10.1161/01.CIR.83.1.13

Sillence, 1991, Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on β2-adrenoceptor density in female rats, Arch Pharmacol, 344, 449, 10.1007/BF00172585

Maltin, 1987, Propranolol apparently separates the physical and compositional characteristics of muscle growth induced by clenbuterol, Biosci Rep, 7, 51, 10.1007/BF01122727

MacLennan, 1989, Effects of clenbuterol and propranolol on muscle mass: evidence that clenbuterol stimulates muscle β-adrenoceptors to induce hypertrophy, Biochem J, 264, 573, 10.1042/bj2640573

Palmer, 1990, Effects of the cyclo-oxygenase inhibitor, fenbufen, on clenbuterol-induced hypertrophy of cardiac and skeletal muscle of rats, Br J Pharmacol, 101, 835, 10.1111/j.1476-5381.1990.tb14166.x

Seymour, 1990, Hyperthyroidism results in increased glycolytic capacity in the rat heart. A 31P-NMR study, Biochim Biophys Acta, 1055, 107, 10.1016/0167-4889(90)90110-Y

Campa, 1990, Application of high-pressure liquid chromatography to studies of collagen production by isolated cells in culture, Anal Biochem, 186, 257, 10.1016/0003-2697(90)90076-L

Laurent, 1981, A simplified method for quantification of the relative amounts of type I and type III collagen in small tissue samples, Anal Biochem, 133, 301, 10.1016/0003-2697(81)90081-6

Chomczynski, 1987, Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2

Mercadier, 1990, Altered sarcoplasmic reticulum Ca2+-ATPase gene expression in the human ventricle during end-stage heart failure, J Clin Invest, 85, 305, 10.1172/JCI114429

Moorman, 1995, Patterns of expression of sarcoplasmic reticulum Ca2+-ATPase and phospholamban mRNAs during rat heart development, Circ Res, 76, 616, 10.1161/01.RES.76.4.616

Maltin, 1993, Clenbuterol, a β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients, Clin Sci, 84, 651, 10.1042/cs0840651

Cihak, 1992, Functional changes in the right and left ventricle during development of cardiac hypertrophy and after its regression, Cardiovasc Res, 26, 845, 10.1093/cvr/26.9.845

Stein, 1996, Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts, Am J Physiol, 270, H2021

Boheler, 1992, Gene expression in cardiac hypertrophy, Trends Cardiovasc Med, 2, 176, 10.1016/1050-1738(92)90046-U

Buttrick, 1994, Alterations in gene expression in the rat heart after chronic pathological and physiological loads, J Mol Cell Cardiol, 26, 61, 10.1006/jmcc.1994.1008

Kuznetsov, 1995, β 2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes, Circ Res, 76, 40, 10.1161/01.RES.76.1.40

Timsit, 1990, Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern and myosin adenosine triphosphatase activity of rat left ventricle, J Clin Invest, 86, 507, 10.1172/JCI114737

Yang, 1995, Growth hormone improves cardiac performance in experimental heart failure, Circulation, 92, 262, 10.1161/01.CIR.92.2.262

Fazio, 1996, A preliminary study of growth hormone in the treatment of dilated cardiomyopathy, N Engl J Med, 334, 809, 10.1056/NEJM199603283341301